Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000241 |
Adenosine |
ADORA2B protein affects the susceptibility to Adenosine | affects response to substance | 16920807
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of ADORA2B protein | affects expression | 20106945
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of ADORA2B mRNA | affects expression | 16483693
|
D003913 |
Dextroamphetamine |
Dextroamphetamine results in decreased expression of ADORA2B mRNA | decreases expression | 12205029
|
D003913 |
Dextroamphetamine |
SOD1 inhibits the reaction [Dextroamphetamine results in decreased expression of ADORA2B mRNA] | decreases expression|decreases reaction | 12205029
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite affects the expression of ADORA2B mRNA | affects expression | 17331233
|
C518875 |
BAY 60-6583 |
BAY 60-6583 binds to and results in increased activity of ADORA2B protein | affects binding|increases activity | 19749167
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of ADORA2B mRNA | increases expression | 20064835 20106945
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ADORA2B mRNA | decreases expression | 20382639
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of ADORA2B mRNA | increases expression | 15336504
|
C006862 |
butylphen |
butylphen results in increased expression of ADORA2B mRNA | increases expression | 10571726
|
D002104 |
Cadmium |
Cadmium results in increased expression of ADORA2B mRNA | increases expression | 21172416
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of ADORA2B mRNA | increases expression | 17484886 18263696
|
D003513 |
Cycloheximide |
[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of ADORA2B mRNA | affects cotreatment|increases expression | 19684285
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of ADORA2B mRNA | increases expression | 20106945
|
D002945 |
Cisplatin |
ADORA2B protein affects the susceptibility to Cisplatin | affects response to substance | 16217747
|
D004137 |
Dinitrochlorobenzene |
Dinitrochlorobenzene results in increased expression of ADORA2B mRNA | increases expression | 16314067
|
D004178 |
Diquat |
Diquat results in increased expression of ADORA2B mRNA | increases expression | 21172416
|
D019830 |
Adenosine-5'-(N-ethylcarboxamide) |
ADORA2B protein affects the susceptibility to Adenosine-5'-(N-ethylcarboxamide) | affects response to substance | 16920807
|
C029938 |
nickel sulfate |
nickel sulfate results in increased expression of ADORA2B mRNA | increases expression | 16314067
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of ADORA2B mRNA | decreases expression | 17426115
|
C045950 |
propiconazole |
propiconazole results in decreased expression of ADORA2B mRNA | decreases expression | 19423681
|
D020849 |
Raloxifene |
[Raloxifene co-treated with ESR2 protein] results in increased expression of ADORA2B mRNA | affects cotreatment|increases expression | 19059307
|
C446685 |
systhane |
systhane results in decreased expression of ADORA2B mRNA | decreases expression | 19423681
|
D013629 |
Tamoxifen |
[Tamoxifen co-treated with ESR2 protein] results in increased expression of ADORA2B mRNA | affects cotreatment|increases expression | 19059307
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of ADORA2B mRNA | affects cotreatment|increases expression | 19684285
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of ADORA2B mRNA | increases expression | 19684285
|
C032910 |
triadimefon |
triadimefon results in decreased expression of ADORA2B mRNA | decreases expression | 19423681
|
C025643 |
vinclozolin |
vinclozolin results in increased expression of ADORA2B mRNA | increases expression | 15686871
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.32 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.62 | 11752688 14514962 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.33 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
3.75 | 15814532 17670903 12690470 |
MESH:D055371 |
Acute Lung Injury |
|
nickel sulfate |
8.44 | 12718980 16100012 11954676 19131640 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
8.44 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.33 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
4.33 | 17638652 11798837 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.52 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.14 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.14 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.38 | 17451421 17308373 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.49 | 15800139 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.75 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.46 | 19015723 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.85 | 19183758 |
MESH:D050197 |
Atherosclerosis |
|
Cadmium |
3.51 | 15687053 |
MESH:D001321 |
Autistic Disorder |
|
Adenosine |
3.89 | 20468076 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.09 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.09 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.56 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.62 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
4.65 | 14601052 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.25 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.26 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
2.26 | 19526202 18382427 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
2.26 | 16912660 15572757 17595753 15775269 16837676 17049068 17242785 15758505 17440819 17952589 17261762 17893378 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.26 | 18855134 19084267 16273361 19288272 16202921 20544844 18351453 18629630 11161223 20390343 19059307 21152245 19103187 19200415 20135344 19011961 19142967 19189210 21138602 17893378 19289846 15565566 20065188 17261762 18984771 18815881 17049068 19155303 20005174 15668708 19487384 20859285 19066611 19189212 17440819 19115204 17242785 19221464 19244106 16818667 16873071 18425577 19410462 18821012 18997820 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.26 | 20435547 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.56 | 16124888 15700767 16011737 3786805 16050911 10355542 16192424 15721981 16097048 15673190 18705752 16227642 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.62 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.28 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
6.29 | 21507988 12907637 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
6.29 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
6.29 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
6.29 | 16924424 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
2.96 | 16685392 12023789 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.54 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
4.54 | 6189445 17066447 18337622 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
8.84 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
8.84 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.24 | 18850075 18670907 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.29 | 15775269 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
10.36 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cadmium |
10.36 | 17332340 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
10.36 | 12371664 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.97 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.20 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.20 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.84 | 15340226 8697196 15668235 12621046 16354765 |
MESH:D002972 |
Cleft Palate |
|
triadimefon |
5.84 | 16781842 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.39 | 15800139 |
MESH:D003093 |
Colitis, Ulcerative |
|
Dinitrochlorobenzene |
3.78 | 19159591 17373747 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
2.32 | 15273666 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.87 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.77 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
triadimefon |
2.77 | 15834900 16875885 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.12 | 14966744 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.14 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
3.97 | 17474826 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dinitrochlorobenzene |
6.92 | 15491423 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
nickel sulfate |
6.92 | 16780908 16823706 11298694 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.32 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.61 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
8.40 | 17308373 17451421 15920148 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
8.40 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
5.98 | 11566570 9327722 19336974 15998439 7179309 4309450 15027814 16177239 10092053 3732212 2869522 17522070 6884620 6623471 15968718 3786805 16227642 7440962 7120509 10915739 19085960 21278145 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diquat |
5.98 | 18164269 18445702 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
5.98 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
7.62 | 12649298 19839026 15033597 12231392 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.62 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
10.25 | 12083418 |
MESH:D004487 |
Edema |
|
Raloxifene |
10.25 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
10.25 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.67 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
8.52 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
8.52 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
2.90 | 19155303 16202921 17893378 20544844 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.82 | 10568697 9294722 |
MESH:D004827 |
Epilepsy |
|
Adenosine |
4.68 | 11404469 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.92 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
6.92 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
6.92 | 16481741 15464296 17638652 15173087 16785472 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.84 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
22.46 | 16045604 61145 12631006 19224547 15959796 16239168 17595544 12795759 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
22.46 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
22.46 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
22.46 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
22.46 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.10 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.23 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.30 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.95 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
13.41 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
13.41 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
13.41 | 20067830 |
MESH:D005756 |
Gastritis |
|
Diquat |
5.35 | 15046732 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.70 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.07 | 16417039 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.99 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.36 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
3.56 | 15102660 15464296 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
4.10 | 19898482 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
4.23 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.05 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.05 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.38 | 11110106 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.40 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.19 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.13 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.38 | 19900420 19110552 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
24.78 | 19176532 18467677 16221962 19772884 |
MESH:D006529 |
Hepatomegaly |
|
propiconazole |
24.78 | 17178688 17178689 |
MESH:D006529 |
Hepatomegaly |
|
systhane |
24.78 | 17178688 17178689 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
24.78 | 12621046 16120746 15340226 |
MESH:D006529 |
Hepatomegaly |
|
triadimefon |
24.78 | 17178689 17178688 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
3.41 | 16200630 16170182 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.81 | 18606429 16354765 15340226 8697196 16959395 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.30 | 16899240 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.99 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.07 | 10903974 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
8.07 | 15787275 17577099 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.07 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.86 | 15338365 |
MESH:D007248 |
Infertility, Male |
|
Diquat |
6.83 | 4850670 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
6.83 | 16467254 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
4.50 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.50 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.49 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.64 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
triadimefon |
9.64 | 15992940 15834900 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.21 | 15604871 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
4.91 | 15464296 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium |
9.48 | 16962696 16322080 16226777 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
9.48 | 12649298 19839026 15190930 18289764 12231392 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
9.48 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
6.69 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
6.69 | 18625569 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
4.56 | 11231351 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.28 | 16973256 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.50 | 16417039 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.99 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.68 | 11903743 16943688 21278145 16221502 17174718 16239168 17334410 11408273 17157831 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Adenosine |
6.44 | 18263696 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
6.44 | 17869086 17640975 18472332 16011737 16136751 15818738 17557913 18263696 12898905 18420326 12632514 18418968 18006644 12632512 14748882 18429990 12546737 17976157 14512876 15876570 18054572 12958196 15370692 12609069 18472094 10355542 15730626 12667390 17698563 17766677 14620537 13678700 18277467 17761835 15673190 15362042 15931870 17708605 12445418 16192424 12649538 17714472 18210741 12741479 16248980 17721639 18395914 18376398 16638106 16027843 15338365 18395095 15925388 12445421 18412020 17631135 17922224 15996030 12389079 18279442 17481882 18187930 17805973 15123356 17900296 14716833 15959796 18205269 11481614 12586293 16097048 18156304 17823541 18339082 18317297 18251166 15052691 17525996 17944888 15650968 16015684 18481824 15893842 16116963 20821823 17565644 18705752 14724832 16033810 18166357 14716496 12666154 15057751 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
6.44 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
6.44 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.44 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
6.48 | 15720792 17285989 15830285 16964402 16246199 |
MESH:D008107 |
Liver Diseases |
|
propiconazole |
6.48 | 19363144 |
MESH:D008107 |
Liver Diseases |
|
triadimefon |
6.48 | 19363144 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.94 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.49 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
24.44 | 18177683 2125692 15890375 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
24.44 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
24.44 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
24.44 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
propiconazole |
24.44 | 19028983 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
24.44 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
24.44 | 16984957 |
MESH:D008113 |
Liver Neoplasms |
|
triadimefon |
24.44 | 19028983 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
21.56 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
21.56 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
propiconazole |
21.56 | 17178689 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
systhane |
21.56 | 17178689 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
21.56 | 12151625 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
triadimefon |
21.56 | 17178689 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
3.80 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
6.27 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
6.27 | 18569708 18520028 18816296 20464547 20869020 17053015 20064080 6695378 20135361 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
6.27 | 6189445 11798837 17225452 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
6.27 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.27 | 19555203 11884234 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.53 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.48 | 11731420 16827153 14580682 19196722 19196723 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.32 | 19453300 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
5.08 | 12374674 17023156 11135225 16248763 12883367 17761969 18332650 16432458 12393984 16809738 15577323 18505091 18176117 |
MESH:D008545 |
Melanoma |
|
Dinitrochlorobenzene |
5.08 | 17334785 12202904 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
5.08 | 12393984 19393235 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
10.74 | 15990972 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
10.74 | 15990972 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
6.20 | 18303189 16966607 16166281 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
6.20 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.56 | 16801185 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.32 | 15863610 |
MESH:D009041 |
Motion Sickness |
|
Dextroamphetamine |
5.29 | 1613127 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.02 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.28 | 16497877 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.28 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.05 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.84 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.77 | 16411023 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.32 | 16343187 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.46 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.44 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
7.61 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
7.61 | 16773208 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
7.61 | 17405874 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.77 | 19200415 19189210 19196722 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
4.26 | 15464296 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.21 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.09 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.00 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
3.33 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
4.47 | 8761367 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.76 | 20558911 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.26 | 19059307 17882678 15775268 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.02 | 15758505 17893378 17823083 15579764 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
2.81 | 19769630 15464296 6897625 17225452 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
2.91 | 19003803 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.02 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
4.09 | 15464296 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Cadmium |
5.15 | 15687053 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.67 | 10923243 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
5.11 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.34 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.03 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.73 | 11118676 11222880 11896295 11399792 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
8.73 | 18042343 18220299 19015723 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.70 | 18220299 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.15 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cadmium |
2.15 | 17075824 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.15 | 16220300 16536755 15731164 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.15 | 15067354 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.70 | 18629315 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.15 | 16882103 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
2.94 | 15814490 17975199 17322281 17365031 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.32 | 15770314 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
4.18 | 15464296 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.28 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.62 | 18990726 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
4.21 | 14601052 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
8.77 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
8.77 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
8.77 | 16192470 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
5.11 | 15464296 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.06 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.81 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.48 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
2.48 | 18396642 15958060 17522103 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.64 | 16837676 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
4.42 | 15464296 17225452 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.67 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
triadimefon |
3.92 | 17178689 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
4.98 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
11.22 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
11.22 | 17225452 12973940 15464296 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
11.22 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
11.22 | 17572228 16712894 8653321 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
4.01 | 16803524 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.75 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
4.39 | 15577323 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.36 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
4.98 | 16837676 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
4.49 | 11897121 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.32 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.02 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.21 | 17120751 |